Success Metrics

Clinical Success Rate
87.1%

Based on 27 completed trials

Completion Rate
87%(27/31)
Active Trials
9(16%)
Results Posted
15%(4 trials)
Terminated
4(7%)

Phase Distribution

Ph early_phase_1
2
4%
Ph phase_2
18
32%
Ph phase_3
10
18%
Ph phase_1
3
5%
Ph not_applicable
18
32%
Ph phase_4
5
9%

Phase Distribution

5

Early Stage

18

Mid Stage

15

Late Stage

Phase Distribution56 total trials
Early Phase 1First-in-human
2(3.6%)
Phase 1Safety & dosage
3(5.4%)
Phase 2Efficacy & side effects
18(32.1%)
Phase 3Large-scale testing
10(17.9%)
Phase 4Post-market surveillance
5(8.9%)
N/ANon-phased studies
18(32.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.4%

27 of 34 finished

Non-Completion Rate

20.6%

7 ended early

Currently Active

9

trials recruiting

Total Trials

56

all time

Status Distribution
Active(10)
Completed(27)
Terminated(7)
Other(12)

Detailed Status

Completed27
unknown11
Recruiting5
Active, not recruiting4
Terminated4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
56
Active
9
Success Rate
87.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.6%)
Phase 13 (5.4%)
Phase 218 (32.1%)
Phase 310 (17.9%)
Phase 45 (8.9%)
N/A18 (32.1%)

Trials by Status

unknown1120%
active_not_recruiting47%
withdrawn35%
suspended12%
completed2748%
recruiting59%
terminated47%
not_yet_recruiting12%

Recent Activity

Clinical Trials (56)

Showing 20 of 56 trialsScroll for more
NCT07492446Not Applicable

Effects of Carnitine Supplementation on Exercise-Induced Muscle Damage: A Randomized Controlled Trial

Completed
NCT07216001Phase 2

Role of Omega-DEK in Childhood Apraxia of Speech

Not Yet Recruiting
NCT07437391Not Applicable

Effect of L-Carnitine Supplementation in Preterm Neonates

Recruiting
NCT07402759Phase 3

Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men

Active Not Recruiting
NCT06960694Phase 2

Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis

Completed
NCT05980884Not Applicable

Using Gut Microbial Gbu Gene Testing to Estimate Host TMAO Production Capacity

Active Not Recruiting
NCT05251207Not Applicable

Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance

Active Not Recruiting
NCT04908397Phase 1

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

Completed
NCT06845046Not Applicable

A Study to Improve Skeletal Muscle in Veterans With HIV

Recruiting
NCT06564909Phase 2

Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI

Recruiting
NCT05355311Phase 1

Enhancing the Effects of Alcohol Treatment With L-Carnitine

Completed
NCT07016867Not Applicable

Medical Treatment Alone Versus Varicocelectomy Versus Varicocelectomy and Medical Treatment

Recruiting
NCT06901323Phase 4

Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria

Active Not Recruiting
NCT05948124Early Phase 1

Carnitine Supplementation in Pediatric Hemodialysis Patients

Unknown
NCT05792527Phase 3

L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis

Recruiting
NCT01783041Phase 2

Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants

Completed
NCT05647707Phase 2

The Efficacy of L-Carnitine in the Management of Acute Carbon Monoxide Poisoning

Unknown
NCT05632094Phase 2

The Efficacy of L-Carnitine in the Management of Acute Clozapine Intoxication

Unknown
NCT05584956Phase 3

Clinical Study to Evaluate the Possible Efficacy and Safety of L- Carnitine and Sildenafil in Children Having Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity

Unknown
NCT03193125Not Applicable

Carnitine and Liver Mitochondria Fatty Acid Processing

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
56